intracranial_solitary_fibrous_tumor_treatment

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revision Previous revision
intracranial_solitary_fibrous_tumor_treatment [2025/07/03 06:49] – [Systematic review and meta‑analysis] administradorintracranial_solitary_fibrous_tumor_treatment [2025/07/03 06:57] (current) – [Systematic review and meta‑analysis] administrador
Line 76: Line 76:
 === Takeaway for practicing neurosurgeon ===   === Takeaway for practicing neurosurgeon ===  
  
-After [[gross total resection]] of [[intracranial solitary fibrous tumor]]s—especially [[WHO]] grade 2 or 3—[[adjuvant]] [[radiotherapy]] appears to provide meaningful improvements in both progression‑free and [[overall survival]]. Given the [[retrospective]] evidence, surgeons and neuro‑oncologists should include PORT in multidisciplinary discussions and patient counseling.+After [[gross total resection]] of [[intracranial solitary fibrous tumor]]s—especially [[WHO]] grade 2 or 3—[[adjuvant]] [[radiotherapy]] appears to provide meaningful improvements in both progression‑free and [[overall survival]]. Given the [[retrospective]] evidence, surgeons and neuro‑oncologists should include PORT in multidisciplinary [[discussion]]s and patient [[counseling]].
  
 **Bottom line**:: In the absence of randomized [[evidence]], PORT is a reasonable addition to surgery for intracranial SFT to extend [[survival]]. **Bottom line**:: In the absence of randomized [[evidence]], PORT is a reasonable addition to surgery for intracranial SFT to extend [[survival]].
  • intracranial_solitary_fibrous_tumor_treatment.txt
  • Last modified: 2025/07/03 06:57
  • by administrador